Krystal Biotech, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
107.25
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
7
|
|
# Buys
|
1
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.22
|
-1.17
|
0.05
|
4.10%
|
|
2022-06-30
|
-1.02
|
-1.10
|
-0.08
|
-7.84%
|
|
2022-03-31
|
-1.05
|
-1.99
|
-0.94
|
-89.52%
|
|
2021-12-31
|
-0.73
|
-0.95
|
-0.22
|
-30.14%
|
|
2021-09-30
|
-0.74
|
-0.70
|
0.04
|
5.41%
|
|
2021-06-30
|
-0.76
|
-0.74
|
0.02
|
2.63%
|
|
2021-03-31
|
-0.56
|
-0.74
|
-0.18
|
-32.14%
|
|
2020-12-31
|
-0.59
|
-0.53
|
0.06
|
10.17%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-4.26
|
|
2021-12-31
|
-3.13
|
|
2020-12-31
|
-1.70
|
|
2019-12-31
|
-1.22
|
|
2018-12-31
|
-0.96
|
|
2017-12-31
|
-1.58
|